Chemours Co. (CC)
Chemours (CC) Misses Q2 Earnings Estimates
Chemours (CC) came out with quarterly earnings of $0.38 per share, missing the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $1.10 per share a year ago.
Earnings Preview: Chemours (CC) Q2 Earnings Expected to Decline
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemours Rises as UBS Upgrades Stock To 'Buy'
The Chemours Co. (CC) shares gained in intraday trading Tuesday following an upgrade from UBS analysts, who said investors have been too negative on the chemical maker's stock.
Chemours (CC) Soars 5.5%: Is Further Upside Left in the Stock?
Chemours (CC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Chemours: Upside After Irregularities, Good 2024-2026E
Chemours' position in the market is up over 22% compared to a market only up 5% since February. The company suspended production temporarily in Mexico due to water scarcity, but the crash following the news of the audit was an overreaction. CC stock's refrigerant segment has significant potential for growth, particularly in applications like data centers.
Chemours (CC) Announces Enhancement of EVOLVE 2030 Methodology
The revised EVOLVE 2030 approach improves Chemours' (CC) ability to integrate its business processes with this goal.
Why Is Chemours (CC) Down 2.1% Since Last Earnings Report?
Chemours (CC) reported earnings 30 days ago. What's next for the stock?
Levi & Korsinsky Notifies Shareholders of The Chemours Company (CC) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / May 20, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
The Chemours Company Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - CC
NEW YORK, NY / ACCESSWIRE / May 20, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - CC
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Shareholders of The Chemours Company Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - CC
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 - CC
NEW YORK, NY / ACCESSWIRE / May 19, 2024 / If you suffered a loss on your The Chemours Company (NYSE:CC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
